Drug Discovery and Development
A section of Biomedicines (ISSN 2227-9059).
Section Information
This section publishes reviews and original peer-reviewed papers of a high scientific level covering all aspects of the biomedical use of natural compounds. Papers aim to review or report the discovery of novel natural compounds, novel medical or health uses of existing natural compounds, bioactivities of natural compounds, pharmaceutical and nutraceutical formulation of natural compounds, new technology for natural compound extraction and purification, pharmacology of natural compounds, combination therapy with natural compounds as supplements, and any new frontiers of natural compound research. Topics include, but are not limited to: in vivo/in vitro bioactivity research, chemical identification and characterization of bioactive natural compounds, clinical study of natural compounds, pharmaceutical formulation of natural compounds (including nano-formulation and prodrug formulation), targeted combination therapies (i.e., synergy between natural compounds and standard chemotherapy), preclinical and clinical pharmacology, synthesis (chemical synthesis and biosynthesis) and modification of natural compounds, and advanced extraction and purification technology to improve yield, purity, and bioactivity.
Editorial Board
Topic Board
Special Issues
Following special issues within this section are currently open for submissions:
- Drug Transporters (Deadline: 31 March 2021)
- Therapeutic Potential of Plant Secondary Metabolites in the Treatment of Diseases and Drug Development (Deadline: 31 March 2021)
- Recent Advances in the Discovery of Novel Drugs on Natural Molecules (Deadline: 15 April 2021)
- Pharmacokinetics of Biomedicines: Impact on Pre-clinical Development and Clinical Use (Deadline: 30 April 2021)
- Peptides of Natural Origins as Leads for Drug Discovery: From Native Structures to Peptidomimetics, Peptide-Conjugates, and Peptide-Nanoparticles (Deadline: 30 April 2021)
- Novel Anticancer Agents: Molecular Mechanisms of Response and Resistance (Deadline: 30 April 2021)
- Biomedicine from the Sea (Deadline: 30 April 2021)
- Periprosthetic Joint Infections: Pathomechanism, Diagnostics and Novel Treatment Options (Deadline: 30 June 2021)
- Immunity, Anti-inflammatory Effects of Antimicrobial Compounds as Alternative Medicine (Deadline: 30 June 2021)
- Non-canonical Functions of Membrane Proteins: Novel Opportunities for Drug Discovery (Deadline: 30 June 2021)
- Advances in Pathogenesis and Treatment of Colonic Diverticular Disease (Deadline: 30 June 2021)
- Advance in Tumor Microenvironment and Drug Delivery (Deadline: 31 July 2021)
- The Therapeutic Effects of Cannabinoids in Neurodegenerative Diseases (Deadline: 31 July 2021)
- The Rise of Alternative (Non-) Antibody Scaffolds Therapeutics (Deadline: 31 July 2021)
- Extracellular vesicles: Molecular research and Application (Deadline: 31 August 2021)
- Approaches to Fight Microbial Infection-Related Biofilms (Deadline: 31 August 2021)
- Anti-Inflammatory Activity of Plant Polyphenols 2.0 (Deadline: 15 September 2021)
- Drug Therapies for Fibromyalgia II (Deadline: 30 September 2021)
- Feature Papers in Drug Discovery and Development (Deadline: 31 December 2021)
- Peptide-Based Drug Development (Deadline: 31 December 2021)
